CEO: Joseph J. Ciaffoni

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.


Key numbers

Market Capitalization:607119640
Shares Outstanding: 33524000
Float: 28519671.376000002
Next Earning Date:2020-03-06
TTm EPS: -0.3413
TTm Dividend Rate:
200 days moving average:13.27
50 days moving average: 12.84
One day percent Change: 43.73



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,